Planetary Health Diet-Compatible Food Substitutions in Obesity: Direct Evidence, Gut–Organ Mechanisms, and Translational Priorities
4 affiliations
- 1The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
- 2Food and Nutritional Sciences, School of Biological Sciences, The University of Hong Kong, Pokfulam Road, Hong Kong, China
- 3Xi’an Center for Disease Control and Prevention, No. 599 Xiying Road, Yanta District, Xi’an 710054, China
- 4Institute of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
Abstract
Background: The Planetary Health Diet (PHD) is a plant-rich reference pattern rather than a validated obesity treatment. Its clinical value is difficult to interpret when direct PHD studies are combined with evidence from related dietary patterns, isolated substrates, and experimental models. Methods: This narrative review searched PubMed/MEDLINE, Web of Science, Scopus, and Google Scholar through September 2026. Evidence was organized as direct PHD evidence, evidence from comparable dietary patterns or components, and predominantly experimental evidence. Human interventions and prospective cohorts were prioritized for clinical conclusions, while mechanistic studies were retained only when they clarified a PHD-compatible substitution or a testable gut–organ pathway. Results: Direct PHD evidence is mainly observational and supports associations with lower obesity risk, central adiposity, diabetes incidence, or metabolic dysfunction-associated steatotic liver disease; randomized studies more often test an energy-restricted program or a related plant-rich pattern. Component trials support effects on liver fat, appetite, barrier biology, and microbial function, but do not establish that a complete PHD produces the same effects. Short-chain fatty acids, bile acids, tryptophan metabolites, barrier signals, endocrine pathways, and redox/mitochondrial stress responses are plausible mediators with substantial tissue and person specificity; processing and food-safety exposures remain contextual modifiers rather than established PHD mechanisms. Conclusions: PHD-compatible food substitutions can be used as a clinically adaptable framework when energy intake, protein and micronutrient adequacy, cultural feasibility, affordability, and tolerability are addressed. Weight, waist, glycemia, hepatic risk, and muscle function should be evaluated separately. The complete PHD–microbiome–organ causal sequence and the added value of microbiome-guided personalization remain unproven.
Related
- Physiological Basis of Skeletal Muscle Electrical Stimulation in Heart Failure with Reduced Ejection Fraction: Established Mechanisms, Extrapolated Mechanisms and Translational Priorities
- Antibody–drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities
- Mushroom-derived polysaccharides in cancer immunotherapy: mechanisms, human evidence, and translational priorities
- Functional peptide therapeutics for veterinary osteoarthritis: mechanisms, delivery systems, and translational priorities
- Bridging the Translational Gap in Artificial Intelligence for Otology and Neurotology: Clinical Readiness, Limitations, and Research Priorities
BibTeX
@article{lin2026planetary,
title = {{Planetary Health Diet-Compatible Food Substitutions in Obesity: Direct Evidence, Gut–Organ Mechanisms, and Translational Priorities}},
author = {Minru Lin and Deju Zhang and Siyao Li and Yinuo Qu and Huiling Cai},
journal = {Nutrients},
year = {2026},
month = oct,
doi = {10.3390/nu18213588},
url = {https://www.mdpi.com/2072-6643/18/21/3588},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Planetary Health Diet-Compatible Food Substitutions in Obesity: Direct Evidence, Gut–Organ Mechanisms, and Translational Priorities
AU - Minru Lin
AU - Deju Zhang
AU - Siyao Li
AU - Yinuo Qu
AU - Huiling Cai
PY - 2026
DA - 2026/10/29
JO - Nutrients
DO - 10.3390/nu18213588
UR - https://www.mdpi.com/2072-6643/18/21/3588
AB - Background: The Planetary Health Diet (PHD) is a plant-rich reference pattern rather than a validated obesity treatment. Its clinical value is difficult to interpret when direct PHD studies are combined with evidence from related dietary patterns, isolated substrates, and experimental models. Methods: This narrative review searched PubMed/MEDLINE, Web of Science, Scopus, and Google Scholar through September 2026. Evidence was organized as direct PHD evidence, evidence from comparable dietary patterns or components, and predominantly experimental evidence. Human interventions and prospective cohorts were prioritized for clinical conclusions, while mechanistic studies were retained only when they clarified a PHD-compatible substitution or a testable gut–organ pathway. Results: Direct PHD evidence is mainly observational and supports associations with lower obesity risk, central adiposity, diabetes incidence, or metabolic dysfunction-associated steatotic liver disease; randomized studies more often test an energy-restricted program or a related plant-rich pattern. Component trials support effects on liver fat, appetite, barrier biology, and microbial function, but do not establish that a complete PHD produces the same effects. Short-chain fatty acids, bile acids, tryptophan metabolites, barrier signals, endocrine pathways, and redox/mitochondrial stress responses are plausible mediators with substantial tissue and person specificity; processing and food-safety exposures remain contextual modifiers rather than established PHD mechanisms. Conclusions: PHD-compatible food substitutions can be used as a clinically adaptable framework when energy intake, protein and micronutrient adequacy, cultural feasibility, affordability, and tolerability are addressed. Weight, waist, glycemia, hepatic risk, and muscle function should be evaluated separately. The complete PHD–microbiome–organ causal sequence and the added value of microbiome-guided personalization remain unproven.
SN - 2072-6643
ER -